![David Urech](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Urech
Gründer bei
Numab Therapeutics AG
Profil
David Urech is the founder of Numab Therapeutics AG, founded in 2011, and holds the title of Director.
Dr. Urech currently works at BioMedPartners AG as a Venture Partner.
Formerly, Dr. Urech was Director-Research & Development at ESBATech, a Novartis Co. GmbH.
Dr. Urech earned a doctorate from the University of Basel and a graduate degree from the University of Zurich.
Aktive Positionen von David Urech
| Unternehmen | Position | Beginn |
|---|---|---|
Numab Therapeutics AG
 Numab Therapeutics AG BiotechnologyHealth Technology Develops antibody-based immunotherapies for inflammation and cancer | Gründer | 01.01.2011 |
BioMedPartners AG
 BioMedPartners AG Investment ManagersFinance BioMedPartners invests in companies located in Switzerland, Germany and neighboring Western Europe. The firm focuses on biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies. It participates in seed and early stage capital transactions. It also makes follow-on investments and acts a lead or co-lead investor. | Private Equity Investor | - |
Ehemalige bekannte Positionen von David Urech
| Unternehmen | Position | Ende |
|---|---|---|
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services Develops antibody fragment therapeutics | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von David Urech
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services Develops antibody fragment therapeutics | Commercial Services |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners invests in companies located in Switzerland, Germany and neighboring Western Europe. The firm focuses on biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies. It participates in seed and early stage capital transactions. It also makes follow-on investments and acts a lead or co-lead investor. | Finance |
Numab Therapeutics AG
Numab Therapeutics AG BiotechnologyHealth Technology Develops antibody-based immunotherapies for inflammation and cancer | Health Technology |
